Press releases 2019

The latest innovation results

In an interview with COSSMA magazine Rishabh Pande, Vice President Marketing & Innovations, reveals what DSM’s latest advances along its innovation strategy are.

DSM and METEX NØØVISTA announce an exclusive global strategic alliance to market the first made-in-Europe non-GMO cosmetic grade PDO (1.3 Propanediol)

This exclusive global strategic collaboration to deliver the first made-in-Europe cosmetic grade of PDO, 100% bio-sourced from non-GMO feedstocks under the DSM TILAMAR® brand, TILAMAR® PDO with NØØVISTA.

DSM seeks FDA approval of PARSOL® SHIELD as a new sunscreen active for use in OTC sunscreen products in the US

DSM’s Personal Care & Aroma Ingredients business unit, one of the industry’s leading suppliers to the personal care, home care and fine fragrance markets, prepares to submit the necessary data to the FDA to support a generally recognized as safe and effective (GRASE) determination for Bemotrizinol (BEMT).

DSM proposes an accelerated scientific approach to confirm GRASE status for UV-filter products in the United States

DSM’s Personal Care & Aroma Ingredients business unit, one of the industry’s leading suppliers to the personal care, home care and fine fragrance markets, proposes an accelerated scientific approach to confirm GRASE status for most UV-filter products in the United States.

DSM explores beauty diversity and showcases new formulations and findings at in-cosmetics Global 2019 in Paris, 2-4 April

DSM Personal Care & Aroma Ingredients will be investigating the future of beauty diversity, presenting innovative personal care formulations and new scientific findings at this year’s in-cosmetics.

DSM showcases Light Medical Beauty options and new breakthrough findings for ALPAFLOR® SCUTELLARIA AO at PCHi, 26-28 February 2019

DSM Personal Care & Aroma Ingredients will showcase non-invasive topical skin care solutions and a new substantiation for its organic skin bioactive ALPAFLOR® SCUTELLARIA AO at this year’s PCHi.

DSM Venturing invests in skin microbiome research

Royal DSM today announced that DSM Venturing, its venture investment arm, has made an equity investment in skin microbiome company S-Biomedic NV.